← Browse by Condition
Medical Condition

recurrent breast cancer

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1
NCT06900647 Phase 1
Recruiting

Bortezomib Plus Cisplatin in Recurrent or Metastatic Breast Cancer

Enrollment
20 pts
Location
China
Sponsor
Sun Yat-sen University
View Trial →